Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01420094 · ClinicalTrials.gov registry record · Phase 3
Evaluate Onset of Action of a Fast Release Aspirin
A Phase 3 study, sponsored by Bayer.
- Completed
- Registry status
- Phase 3
- Development phase
- 510
- Enrollment target
NCT01420094 is a Phase 3 study that has completed, run by Bayer. The registered enrollment target is 510 participants.
The verdict
NCT01420094, a Phase 3 study, has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 510 participants
- Enrollment target
Study Summary
To compare the safety and efficacy (onset, duration of relief and overall efficacy) of a single dose of a fast release formulation of aspirin 1000 mg compared to acetaminophen 1000 mg and placebo for relief of pain following extraction of impacted third molars.
Interventions
- DRUG Placebo
- DRUG Acetylsalicyclic acid (Fast release Aspirin, BAY1019036)
- DRUG Acetaminophen (Tylenol extra strength)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 510 participants |
| Start Date | 2011-06-16 |
| Est. Completion | 2011-09-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01420094
The ClinicalTrials.gov registry entry for NCT01420094 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 510 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01420094 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01420094 about?
NCT01420094 is a clinical study titled "Evaluate Onset of Action of a Fast Release Aspirin". To compare the safety and efficacy (onset, duration of relief and overall efficacy) of a single dose of a fast release formulation of aspirin 1000 mg compared to acetaminophen 1000 mg and placebo for relief of pain following extraction of impacted third molars.
What is the current status of trial NCT01420094?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 510 participants. The study started on 2011-06-16. Estimated completion is 2011-09-08.
What interventions are being tested in trial NCT01420094?
The interventions under investigation include: Placebo (DRUG), Acetylsalicyclic acid (Fast release Aspirin, BAY1019036) (DRUG), Acetaminophen (Tylenol extra strength) (DRUG).
Who is sponsoring clinical trial NCT01420094?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.